Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-24 @ 11:59 AM
Study NCT ID:
NCT04232761
Status:
COMPLETED
Last Update Posted:
2024-07-17
First Post:
2020-01-15
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Gather Information on the Safety and How Radium-223 Dichloride, an Alpha Particle-emitting Radioactive Agent, Works Under Routine Clinical Practice in Taiwan in Patients With Castration-resistant Prostate Cancer (CRPC) Which Has Spread to the Bone
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-29
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-15
First Submit QC Date:
None
Study First Post Date:
2020-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-16
Last Update Post Date:
2024-07-17
Last Update Post Date Type:
ACTUAL